Cargando…
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: To evaluate the efficacy of two doses of the adsorbed vaccine COVID-19 (inactivated) produced by Sinovac in symptomatic individuals, with virological confirmation of COVID-19, two weeks after the completion of the two-dose vaccination regimen, aged 18 years or older who work as health pr...
Autores principales: | Palacios, Ricardo, Patiño, Elizabeth González, de Oliveira Piorelli, Roberta, Conde, Monica Tilli Reis Pessoa, Batista, Ana Paula, Zeng, Gang, Xin, Qianqian, Kallas, Esper G., Flores, Jorge, Ockenhouse, Christian F., Gast, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558252/ https://www.ncbi.nlm.nih.gov/pubmed/33059771 http://dx.doi.org/10.1186/s13063-020-04775-4 |
Ejemplares similares
-
Profile: Sinovac
por: Yang, Helen
Publicado: (2013) -
From trials to the public health: pre-exposure prophylaxis for HIV prevention
por: Kallas, Esper Georges, et al.
Publicado: (2013) -
Adverse event of Sinovac Coronavirus vaccine: Deafness
por: Zhao, Hai, et al.
Publicado: (2022) -
Safety and immunogenicity of Sinovac’s prototype pandemic influenza H5N1 vaccines: a review on clinical trials
por: Qiu, Yuan‐Zheng, et al.
Publicado: (2008) -
Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis
por: Bencharattanaphakhi, Rungrot, et al.
Publicado: (2021)